Capital Health Regional Medical Center has become the first hospital in New Jersey to employ the Embotrap II Revascularization Device for treatment of stroke, the Trenton-based facility said.
Neurosurgeons at Capital Health’s Capital Institute for Neuroscience use Embotrap II to remove a blood clot in the brain causing a stroke. The stent retriever features a fine, mesh-like end and is guided through a major artery to trap the clot.
"As one of the tools that we use to treat ischemic stroke, Embotrap II has a design that has been shown to trap clots that are causing the blockage of blood flow in the brain while retaining its shape, making it faster and more effective at retrieving the clot, restoring blood flow to the brain and ultimately providing a better outcome," said Capital Institute for Neurosciences’ Stroke and Cerebrovascular Center’s Dr. Vernard Fennell in a release.
Fennell also participated in initial research for Embotrap II’s design.
Embotrap II received approval from the U.S. Food and Drug Administration in July.